Related Experiment Video
Updated: Mar 16, 2026

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
Published on: July 19, 2024
Markov models of the apo-MDM2 lid region reveal diffuse yet two-state binding dynamics and receptor poses for
Sudipto Mukherjee1, George A Pantelopulos1, Vincent A Voelz1
1Department of Chemistry, Temple University, Philadelphia, PA, USA.
Abstract:
MDM2 is a negative regulator of p53 activity and an important target for cancer therapeutics. The N-terminal lid region of MDM2 modulates interactions with p53 via competition for its binding cleft, exchanging slowly between docked and undocked conformations in the absence of p53. To better understand these dynamics, we constructed Markov State Models (MSMs) from large collections of unbiased simulation trajectories of apo-MDM2, and find strong evidence for diffuse, yet two-state folding and binding of the N-terminal region to the p53 receptor site. The MSM also identifies holo-like receptor conformations highly suitable for computational docking, despite initiating trajectories from closed-cleft receptor structures unsuitable for docking. Fixed-anchor docking studies using a test set of high-affinity small molecules and peptides show simulated receptor ensembles achieve docking successes comparable to cross-docking studies using crystal structures of receptors bound by alternative ligands. For p53, the best-scoring receptor structures have the N-terminal region lid region bound in a helical conformation mimicking the bound structure of p53, suggesting lid region association induces receptor conformations suitable for binding. These results suggest that MD + MSM approaches can sample binding-competent receptor conformations suitable for computational peptidomimetic design, and that inclusion of disordered regions may be essential to capturing the correct receptor dynamics.
Insights
Markov State Models reveal how the MDM2 protein
Area of Science:
- Computational Biology
- Structural Biology
- Drug Discovery
Background:
- MDM2 is a key negative regulator of p53 tumor suppressor activity.
- MDM2 is a significant target for developing novel cancer therapeutics.
- The N-terminal lid region of MDM2 influences p53 binding by competing for the p53 binding cleft.
Purpose of the Study:
- To elucidate the dynamic conformational changes of apo-MDM2 (MDM2 without p53).
- To understand the folding and binding mechanisms of the MDM2 N-terminal region.
- To assess the utility of MDM2 dynamics in computational drug design against cancer.
Main Methods:
- Construction of Markov State Models (MSMs) from extensive unbiased molecular dynamics simulations of apo-MDM2.
- Analysis of N-terminal lid region dynamics and its conformational states.
- Fixed-anchor docking studies utilizing simulated receptor ensembles against known ligands.
Main Results:
- MSMs revealed a two-state folding and binding mechanism for the MDM2 N-terminal region.
- Identified holo-like MDM2 conformations suitable for computational docking, even from closed-cleft starting structures.
- Simulated ensembles achieved docking success rates comparable to cross-docking studies using crystal structures.
Conclusions:
- MDM2 + MSM approaches effectively sample binding-competent receptor conformations.
- These methods are suitable for computational peptidomimetic design targeting MDM2.
- Inclusion of disordered regions is crucial for accurately capturing receptor dynamics relevant to drug design.
More Related Videos
05:50Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Related Concept Videos
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites
The Equilibrium Binding Constant and Binding Strength
Cooperative Allosteric Transitions
Cooperative Allosteric Transitions